Magnesium on RX Imola analyser IVD
FDA Device Recall #Z-0725-2017 — Class II — April 14, 2016
Recall Summary
| Recall Number | Z-0725-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 14, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Randox Laboratories, Limited |
| Location | Crumlin, N/A |
| Product Type | Devices |
| Quantity | 15 |
Product Description
Magnesium on RX Imola analyser IVD
Reason for Recall
According to the firm, Carry over was observed when the amylase or pancreatic amylase test is run directly before or after the Magnesium assay. An update is required to the RX Imola analyser running order and an acid wash recommended when setting up the magnesium assay. A correction was made to the IFU for the Magnesium assay and all RX Imola customers in the USA were contacted with the updated instruction.
Distribution Pattern
Nationwide Distribution The product was only distributed to US Consignees.
Lot / Code Information
reagent: MG3880 analyser: RX4900
Other Recalls from Randox Laboratories, Limited
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1018-2025 | Class II | Randox Lipoprotein (a) - In vitro diagnostic (I... | Dec 20, 2024 |
| Z-1017-2025 | Class II | Randox Lipoprotein (a) - In vitro diagnostic (... | Dec 20, 2024 |
| Z-1349-2020 | Class II | RX Daytona Plus (with ISE/without ISE); Models ... | Dec 19, 2019 |
| Z-0414-2020 | Class II | Randox Liquid Cardiac Controls Catalogue Number... | Oct 4, 2019 |
| Z-0412-2020 | Class II | Randox Liquid Cardiac Controls Catalogue Number... | Oct 4, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.